Lumexa Imaging Holdings, Inc.
- LMRI ยท Nasdaq
- Services-Medical Laboratories
- Raleigh, NC
- CIK 0002071288
Updated from SEC filings through
Top things to know
Executives
-
Caitlin Zulla Chief Executive Officer and Director 10-K, 2026-03-30 -
J. Anthony Martin Chief Financial Officer 10-K, 2026-03-30 - James Anthony Martin Chief Financial Officer 4, 2026-01-15
- James E. Walker, Jr. Chief Accounting Officer 10-K, 2026-03-30
- Russell Stewart Chief Medical Officer 4, 2025-12-16
- Julie Szeker Chief Legal Officer & Corp Sec 4, 2025-12-16
What leadership is saying
“During the second quarter, we continued to build on our momentum, delivering strong same-center growth, expanding our mix of advanced imaging and ramping new centers”
Earnings press release (8-K Ex. 99.1), filed August 12, 2026
Lumexa Imaging Holdings, Inc. is a U.S. public company in services-medical laboratories (SIC 8071), headquartered in Raleigh, NC. It trades as LMRI on Nasdaq. Caitlin Zulla is Chief Executive Officer and Director.
Five-year financials
We have no annual financials for this company yet.
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Caitlin Zulla | Chief Executive Officer and Director | 10-K, 2026-03-30 |
| J. Anthony Martin Proven Finance Executive For High Growth Health Care Providers | Chief Financial Officer | 10-K, 2026-03-30 |
| James Anthony Martin | Chief Financial Officer | 4, 2026-01-15 |
| James E. Walker, Jr. | Chief Accounting Officer | 10-K, 2026-03-30 |
| Russell Stewart Chief Medical Officer | AI in Healthcare | Academic Physician | Chief Medical Officer | 4, 2025-12-16 |
| Julie Szeker | Chief Legal Officer & Corp Sec | 4, 2025-12-16 |
| James Edward Walker Jr. | Principal Accounting Officer | 4, 2026-02-27 |
| Lee Cooper | Chair of the Board | 10-K, 2026-03-30 |
| Brett Brodnax | Director | 10-K, 2026-03-30 |
| Brian Regan | Director | 10-K, 2026-03-30 |
| Bridget Karlin | Director | 10-K, 2026-03-30 |
| Glenn Eisenberg | Director | 10-K, 2026-03-30 |
| Molly Joseph | Lead Independent Director | 10-K, 2026-03-30 |
What Lumexa Imaging Holdings, Inc. does
We are one of the largest national providers of diagnostic imaging services. Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of December 31, 2025, we and our affiliates operated the second largest1 outpatient imaging center footprint in the United States.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 96.1 million (as of August 12, 2026) | 10-Q, August 13, 2026 |
|---|---|---|
| Reportable segments | 2 (period ending June 30, 2026) | 10-Q, August 13, 2026 |
| Latest proxy statement | Meeting June 10, 2026 (filed April 28, 2026) | DEF 14A, April 28, 2026 |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| May 19, 2026 | Brett Brodnax Director | Buy | 35,000 | $254K | Form 4, May 21, 2026 |
| May 14, 2026 | Henry Lee Cooper Director | Buy | 30,000 | $223K | Form 4, May 18, 2026 |
Recent 8-K events
- 8-K filed 2026-08-12
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-30
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-06-12
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-12
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-04-09
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-03-26
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-03-02
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-01-15
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2025-12-18
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2025-12-12
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 8.01 Other events
Frequently asked questions about Lumexa Imaging Holdings, Inc.
- What does Lumexa Imaging Holdings, Inc. do?
- In its own words, from Item 1 of its 10-K: "We are one of the largest national providers of diagnostic imaging services. Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of December 31, 2025, we and our affiliates operated the second largest1 outpatient imaging center footprint in the United States."
- Who is the CEO of Lumexa Imaging Holdings, Inc.?
- Caitlin Zulla, Chief Executive Officer and Director, as named in a 10-K filed March 30, 2026.
- Who is the CFO of Lumexa Imaging Holdings, Inc.?
- J. Anthony Martin, Chief Financial Officer, as named in a 10-K filed March 30, 2026.
- Where is Lumexa Imaging Holdings, Inc. headquartered?
- Raleigh, NC.
- What is Lumexa Imaging Holdings, Inc.'s stock ticker?
- LMRI on Nasdaq.
- What industry is Lumexa Imaging Holdings, Inc. in?
- Services-Medical Laboratories, SIC code 8071.
- What is Lumexa Imaging Holdings, Inc.'s website?
- lumexaimaging.com. Investor relations: https://ir.lumexaimaging.com/.
- When does Lumexa Imaging Holdings, Inc. report earnings next?
- November 10, 2026 at 16:30. Source: pg_future_events.
- Is Lumexa Imaging Holdings, Inc. a public company?
- Yes. Lumexa Imaging Holdings, Inc. files with the SEC under CIK 0002071288 and trades as LMRI.
- How many shares of Lumexa Imaging Holdings, Inc. are outstanding?
- 96.1 million shares as of August 12, 2026, from its 10-Q filed August 13, 2026.
- How many business segments does Lumexa Imaging Holdings, Inc. report?
- 2 reportable segments for the period ending June 30, 2026, from its 10-Q filed August 13, 2026.
- When is Lumexa Imaging Holdings, Inc.'s annual shareholder meeting?
- June 10, 2026, per its proxy statement (DEF 14A) filed April 28, 2026.
- Have Lumexa Imaging Holdings, Inc. insiders traded stock recently?
- Since May 14, 2026, officers and directors reported 0 open-market sales and 2 purchases worth about $477K on Forms 4 and 5. The most recent: Brett Brodnax (Director) bought 35,000 shares on May 19, 2026.